TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
TOVX fundamentals
Theriva Biologics (TOVX) released its earnings on Aug 11, 2025: revenue was -- (YoY --), beat estimates; EPS was -1.93 (YoY +82.05%), missed estimates.
Revenue / YoY
--
--
EPS / YoY
-1.93
+82.05%
Report date
Aug 11, 2025
EPS
Actual | -50 | -45 | -35 | -35 | -32.5 | -5 | -5 | -5 | -7.5 | -7.75 | -8.25 | -9.25 | -7.5 | -8.5 | -4.75 | -7.75 | -7.5 | -10.75 | -6.81 | 6.03 | -1.55 | -1.93 | ||||||||||
Forecast | -67.5 | -40 | -42.5 | -20 | -5 | -5 | -7.5 | -6.25 | -7.5 | -8.75 | -9.25 | -8.375 | -8.875 | -9 | -10.5 | -10.25 | -4.75 | -4.75 | -6.25 | -7.22 | -4.19 | -0.775 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +25.93% | -12.50% | +17.65% | -75.00% | -550.00% | 0.00% | +33.33% | +20.00% | 0.00% | +11.43% | +10.81% | -10.45% | +15.49% | +5.56% | +54.76% | +24.39% | -57.89% | -126.32% | -8.96% | +183.52% | +63.01% | -149.03% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Theriva Biologics's latest dividend and current dividend yield?What guidance did Theriva Biologics's management provide for the next earnings period?What is the revenue and EPS growth rate for Theriva Biologics year over year?What were the key takeaways from Theriva Biologics's earnings call?What is the market's earnings forecast for Theriva Biologics next quarter?What does Theriva Biologics do and what are its main business segments?Did Theriva Biologics beat or miss consensus estimates last quarter?What were the key takeaways from Theriva Biologics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
